Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmketamine combined with dexmedetomidine for perioperative neurocognitive disorder in elderly patients under general anesthesia
ChiCTR2000038829Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esketamine and dexmedetomidine in perioperative neurocognitive disorder (4 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoint: Incidence of perioperative neurocognitive disorder. Started Oct 2020; status: recruiting.
02
Drugs
esketaminedexmedetomidine
03
Conditions
perioperative neurocognitive disorder
Beyond the preview
Go deeper on ChiCTR2000038829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038829.